Denise Wilcox

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index2.1kcitations92works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(67), Multiple Myeloma Research and Treatments(52), CAR-T cell therapy research(23), Ubiquitin and proteasome pathways(22), Cancer-related gene regulation(13)

Publications92 total

Data from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Data from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 1 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 6 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 4 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 2 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 6 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 2 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 4 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 5 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 1 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 5 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 3 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental Figure 3 from Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
2023Open Access
Supplemental table 1 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
Supplemental figure 14 to 17 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
Supplemental figure legends from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
Supplemental table 4 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
Supplemental figure 20 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
Supplemental figure 13 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Keith F. McDaniel(28), Daniel H. Albert(28), Warren M. Kati(26), Emily J. Faivre(25), Tamar Uziel(22), George S. Sheppard(20), John K. Pratt(20), Dachun Liu(20), Lisa Hasvold(20), Leiming Li(20), Mai H. Bui(19), Steven W. Elmore(18), Scott E. Warder(17), Lloyd T. Lam(16), Yu Shen(16), Peer B. Jacobson(15), Xiaoyu Lin(15), Steve Fidanze(15), Saul H. Rosenberg(15), Yu Shen(15)